Sai Sheng Pharmaceutical: Shareholder Ma Li has reduced their holdings by 1.33%.

Sai Sheng Pharmaceutical announced that Ma Li, the controlling shareholder and actual controller of the company, had previously disclosed a plan to reduce her holdings by up to 9.6333 million shares, accounting for 2% of the total share capital of the company from October 21, 2025 to January 20, 2026. As of January 20, 2026, Ma Li has already reduced her holdings by 6.41 million shares, accounting for 1.33%, through centralized bidding and block trading. Among them, she reduced 4.81 million shares from November 18, 2025 to January 14, 2026 at a price of 12.07 yuan per share, and 1.6 million shares from January 13, 2026 to January 19, 2026 at a price of 10.36 yuan per share. Liu Shuqin has not reduced her holdings, and her reduction plan has expired.